DOI: http://dx.doi.org/10.18203/2349-2902.isj20205360

A comparative study of the efficacy of nanocrystalline silver gel and silver sulfadiazine cream on the healing of second degree burn wound

Bikash Maiti, Sabyasachi Bakshi

Abstract


Background: The final aim of burn management is to prevent infection, to promote early epithelialization as well as healing of wound and betterment of functional and asthetic after effects. The present study aimed to compare the effect of nano crystalline silver gel and silver sulfadiazine cream on the healing of second-degree burn wounds.

Methods: After matching the inclusion and exclusion criteriaburn wounds of patients were divided into two parts (sides); one part was dressed with silver sulfadiazine cream and the other one was dressed with nano crystalline silver gel. The wound dressing was changed everyday after washing the wound with normal saline. Wound parameters were measured on the ninth day and twenth day of dressing, using clinical assessment and photographic tool. The obtained data were statistically analyzed using the Chi-square test.

Results: In our study, most patients were noted to have increased epithelization, increased granulation tissue, decreased inflammation, decreased wound infection as well as decreased slough following dressing with both nanocrystalline silver gel and silver sulfadiazine cream but there were more in numbers of patients dressing with nanocrystalline silver gel.

Conclusions: The effect of nanocrystalline silver gel on the reduction of the healing time and necrotic tissue amount and increasing the granulation, epithelialization, and necrotic tissue type was greater. Considering the above findings nanocrystalline silver gel is more recommended to be used for burn wounds.


Keywords


Nanocrystalline silver, Silver sulfadiazine, Wound, Burn, Healing

Full Text:

PDF

References


Burns fact sheet. Available at: http://www.who.int/ news-room/fact-sheets/detail/burns. Accessed on 08 May 2018.

Black JM, Hawks JH. Medical surgical nursing clinicalmanagement. 8th ed. USA: Saunders/ Elsevier; 2009.

Van Loey NE, Maas CJ, Faber AW, Taal LA. Predictors of chronic posttraumatic stress symptoms following burn injury: Results of a longitudinal study. J Trauma Stress. 2003;16:361-9.

Stanford W, Rappole BW, Fox CL. Clinical experience with silver sulfadiazine, a new topical agent for control of Pseudomonas infections in burns. J Trauma. 1969;9:377-88.

Abedini F, Ahmadi A, Yavari A, Hosseini V, Mousavi S. Comparison of silver nylon wound dressing and silver sulfadiazine in partial burn wound therapy. Int Wound J. 2013;10:573-8.

Muller MJ, Hollyoak MA, Moaveni Z, Brown TL, Herndon DN, Heggers JP, et al. Retardation of wound healing by silver sulfadiazine is reversed by Aloe vera and nystatin. Burns. 2003;29:834-6.

Chaby G, Viseux V, Poulain JF, De Cagny B, Denoeux JP, Lok C, et al. Topical silver sulfadiazine-induced acute renal failure. Ann Dermatol Venereol. 2005;132:891-3.

Fraser JF, Cuttle L, Kempf M, Kimble RM. Cytotoxicity of topical antimicrobial agents used in burn wounds in Australasia. ANZ J Surg. 2004;74: 139-42.

Naghsh N, Safari M, Hajmehrabi P. Investigating the effectof silver nanoparticles on E. coli growth. Qom Univ Med Sci J. 2009;6:65-8.

Shiryazdi SM. Compare immediate effect of betadine,sterillum and silver nanoclouids in hand disinfection beforesurgery. J Med Microbiol. 1993;8: 35-40.

Chen X, SchluesenerHJ. Nanosilver: a nano product inmedical application. Toxicol Lett. 2008;176:1-12.

Rai MK, Deshmukh SD, Ingle AP, Gade Ak. Silvernanoparticles: the powerful nanoweapon against multidrugresistant bacteria. J Appl Microbiol. 2012;112:841-52.

Vlachou E. The safety of nanocrystalline silver dressingson burns: A study of systemic silver absorption. Burns. 2007;33:979-85.

Adhya A, Bain J, Ray O, Hazra A, Adhikari S, et al. Healing of burn wounds by topical treatment: A randomized controlled comparison between silver sulfadiazine and nano-crystalline silver. J Basic Clin Pharm. 2015;6:29-34.

Fox CL. Silver sulphadiazine, addendum to local therapy. New York: Harper and Row; 1967.

Voight D, Paul C. The use of Acticoat as silver impregnated telfa dressings in a regional burn and wound care center: the clinicians view. Wounds. 2011;13:11-23.

Dunn K, Edwards-Jones V. The role of Acticoat with nanocrystallinesilver in the management of burns. Burns. 2004;30(Supp 1):S1-9.

Tredget EE, Shankowsky HA, Groeneveld A, Burrell R. A matched-pair, randomized study evaluating the efficacy and safety of Acticoat silver-coated dressing for the treatment of burn wounds. J Burn Care Rehabil. 1998;19(6):531-7.

Varas R, O’Keefe T, Namia N, Pizano LR, Tellachea MH, Rashid Q, et al. A prospective, randomized trial of Acticoat versus silver sulfadiazine in the treatment of partial thickness burns: which method is less painful?. J Burn Care and Rehabil. 2005;26:344-7.

Fong J. The use of silver products in the management of burn wounds:change in practice for the burn unit at Royal Perth Hospital. Aus J Wound Manage. 2005;13:S16-22.

Heggers J, Goodheart RE, Washington J, McCoy L, Carino E, Dang T, et al. Therapeutic efficacy of three silver dressings in an infected animal model. J Burn Care Rehabil. 2005;26(1):53-6.

Lansdown AB. Silver. I: Its antibacterial properties and mechanism of action. J Wound Care. 2002;11 (4):125-30.

Maple PA, Hamilton-Miller JM, Brumfitt W. Comparison of the in-vitro activities of the topical antimicrobials azelaic acid, nitrofurazone, silver sulphadiazine and mupirocin against methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother. 1992;29:661-8.

Taylor PL, Ussher AL, Burrell RE. Impact of heat on nanocrystalline silver dressings. Biomaterials. 2005; 26:7221-9.

Wright JB, Lam K, Buret AG, Olson ME, Burrell RE. Early healing events in a porcine model of contaminated wounds: Effects of nanocrystalline silver on matrix metalloproteinases, cell apoptosis, and healing. Wound Repair Regen. 2002;10:141-51.

Wright J, Lam K, Burrell R. Wound management in an era of increasingbacterial antibiotic resistance: a role for topical silver treatment. Am J Infect Control. 1998;26:572-7.

Wright JB, Hansen DL, Burrell RE. The comparative efficacy of two antimicrobial barrier dressings: In vitro examination of two controlled release of silver dressings. Wounds. 1998;10:179-88.

Robson MC. Wound infection. A failure of wound healing caused by an imbalance of bacteria. Surg Clin North Am. 1997;77:637-50.

Kirshner R. Matrix metalloproteinases in normal and impaired wound healing: A potential role of nanocrystalline silver. Wounds. 2002;13:4-14.